173 related articles for article (PubMed ID: 10851568)
41. Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants.
Nybo M; Dieperink H; Kristensen SR
Nephrol Dial Transplant; 2006 Apr; 21(4):1060-5. PubMed ID: 16384821
[TBL] [Abstract][Full Text] [Related]
42. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation.
Favaloro EJ; Bonar R; Duncan E; Earl G; Low J; Aboud M; Just S; Sioufi J; Street A; Marsden K;
Thromb Haemost; 2006 Jul; 96(1):73-8. PubMed ID: 16807654
[TBL] [Abstract][Full Text] [Related]
43. Acquired hypoprothrombinemia: effects of danazol treatment.
Williams S; Linardic C; Wilson O; Comp P; Gralnick HR
Am J Hematol; 1996 Dec; 53(4):272-6. PubMed ID: 8948670
[TBL] [Abstract][Full Text] [Related]
44. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor].
Komiyama Y; Munakata M; Masuda M; Kagawa H; Fukuhara S; Takahashi H
Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416
[TBL] [Abstract][Full Text] [Related]
45. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
Borucki K; Töpfer G; Hartung KJ; Lutze G
Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
[TBL] [Abstract][Full Text] [Related]
46. Total knee replacement in a patient with lupus anticoagulant.
Bhagia UT; Corpe RS; Steflik D
J South Orthop Assoc; 1997; 6(3):231-4. PubMed ID: 9322205
[TBL] [Abstract][Full Text] [Related]
47. [Acquired factor V inhibitor: 3 cases report and literature review].
Yang YH; Wang HM; Xue F; Liu XF; Liu YZ; Zhang L; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):294-8. PubMed ID: 22781721
[TBL] [Abstract][Full Text] [Related]
48. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
Huang YW; Saidi P; Philipp C
Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
[TBL] [Abstract][Full Text] [Related]
49. Acquired hemophilia a in a patient with lumbar disc herniation: a case report and review of the literature.
Li J; Shen H; Hou T; Li M; He S; Zhang H
Spine (Phila Pa 1976); 2009 Apr; 34(8):E305-8. PubMed ID: 19365240
[TBL] [Abstract][Full Text] [Related]
50. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
51. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
[TBL] [Abstract][Full Text] [Related]
52. Acquired symptomatic inhibitors of plasma clotting factors in nonhemophilic children.
Ryan BR; Arkel Y; Walters TR; Frimmer D; Desposito F
Am J Pediatr Hematol Oncol; 1986; 8(2):144-8. PubMed ID: 3740368
[TBL] [Abstract][Full Text] [Related]
53. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus.
Yin ET; Gaston LW
Thromb Diath Haemorrh; 1965 Sep; 14(1-2):88-115. PubMed ID: 16955969
[TBL] [Abstract][Full Text] [Related]
54. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
Pejsa V; Grgurević I; Kusec R; Gaćina P
Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
[TBL] [Abstract][Full Text] [Related]
55. [Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis].
Takaku T; Kuriyama Y; Shoji N; Otawa M; Gotoh A; Miyazawa K; Fukutake K; Ohyashiki K
Rinsho Ketsueki; 2002 Dec; 43(12):1050-4. PubMed ID: 12607994
[TBL] [Abstract][Full Text] [Related]
56. A fatal case of malignant atrophic papulosis (Degos' disease) in a man with factor V Leinden mutation and lupus anticoagulant.
Hohwy T; Jensen MG; Tøttrup A; Steiniche T; Fogh K
Acta Derm Venereol; 2006; 86(3):245-7. PubMed ID: 16710585
[TBL] [Abstract][Full Text] [Related]
57. A circulating lupus-like coagulation inhibitor induced by chlorpromazine.
Tollefson G; Rodysill K; Cusulos M
J Clin Psychopharmacol; 1984 Feb; 4(1):49-51. PubMed ID: 6420448
[TBL] [Abstract][Full Text] [Related]
58. Inhibitor to factor V in severe factor V congenital deficiency. A case report.
Mazzucconi MG; Solinas S; Chistolini A; Motta M; Mariani G
Nouv Rev Fr Hematol (1978); 1985; 27(5):303-5. PubMed ID: 4080539
[TBL] [Abstract][Full Text] [Related]
59. Acquired inhibitor of factor V: first report in China and literature review.
Lu L; Liu Y; Wei J; Zhang L; Zhang L; Yang R
Haemophilia; 2004 Sep; 10(5):661-4. PubMed ID: 15357793
[TBL] [Abstract][Full Text] [Related]
60. Pericardial effusion in a patient with acquired factor V inhibitor.
Bulcão Macedo FY; Coterell S; Sidney D; Bellaguarda E; Franco R; Castrellon A; Byrnes J
Ann Hematol; 2008 Apr; 87(4):339-41. PubMed ID: 18040686
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
